Octopus Ventures
Status
ACTIVE
Global HQ
London, United Kingdom
Countries of investment
- Austria
- Belgium
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Latvia
- Lithuania
- Luxembourg
- Malta
- Netherlands
- Norway
- Poland
- Portugal
- Romania
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- United Kingdom
- United States
Investment stages
- Pre-Seed
- Seed
- Series A
- Series B
Industries
- AI
- Robotics
- Energy
- Health Tech
- Biotechnology
- Cybersecurity
- B2B Software
- Fintech
- Climate Tech
- Deep Tech
About
Octopus Ventures is the London-based venture capital arm of Octopus Investments, investing across Europe, and selectively in the United States, from pre-seed to growth in B2B software, bio, climate, consumer, deep tech, fintech and health. In November 2026 it held the first close, of undisclosed size, of First Cheque II, its second dedicated pre-seed fund, which targets more than $26.7M, over double the roughly $13M First Cheque I that backed more than 80 companies including OLIX and Prima Mente. The new fund focuses on AI infrastructure, robotics, health and biology, digital security, industrial operating systems and energy across the UK and Europe. As part of the launch Octopus took over the fund, portfolio and operations of the early-stage platform Onstage, bringing six companies including Serova Bio into First Cheque II and adding Onstage co-founder Taos Edmondson as a venture partner.
Octopus Ventures is the London-based venture capital arm of Octopus Investments, investing across Europe, and selectively in the United States, from pre-seed to growth in B2B software, bio, climate, consumer, deep tech, fintech and health. In November 2026 it held the first close, of undisclosed size, of First Cheque II, its second dedicated pre-seed fund, which targets more than $26.7M, over double the roughly $13M First Cheque I that backed more than 80 companies including OLIX and Prima Mente. The new fund focuses on AI infrastructure, robotics, health and biology, digital security, industrial operating systems and energy across the UK and Europe. As part of the launch Octopus took over the fund, portfolio and operations of the early-stage platform Onstage, bringing six companies including Serova Bio into First Cheque II and adding Onstage co-founder Taos Edmondson as a venture partner.
Investment Thesis
Octopus Ventures invests across B2B software, bio, climate, consumer, deep tech, fintech and health, with pre-seed to Series A as its sweet spot and the ability to keep backing companies into later growth rounds. At pre-seed it writes a standard single cheque of about $133K into founders who may not yet have a product, while seed and later cheques typically start at about $1.3M and usually lead the round. It stands out as one of the largest and most active venture investors in Europe, drawing on the wider Octopus Investments group, a network of more than 180 backed founders, and in-house mentorship and talent teams.
Manager's Experience
Kirsten Connell, Partner, joined Octopus Ventures in 2021 to set up First Cheque Fund after five years at Seedcamp, where she backed companies such as Wise, UiPath and Revolut, and after serving as managing director of the deep tech and cybersecurity accelerator CyLon, which supported more than 60 startups including Tessian and Immersive Labs. CEO Erin Platts joined in January 2025 after more than two decades building HSBC Innovation Banking UK, formerly Silicon Valley Bank UK, to over 800 staff across six countries. Tilly Fleming, who co-leads First Cheque II with Connell, previously spent about six years in venture at Venrex.
Team
Erin Platts - CEO
Kirsten Connell - Partner Pre-seed
Paul Davidson - Partner B2B Software
Will Gibbs - Partner Health
Edward Keelan - Partner
Uthish Ranjan - Partner
Tilly Fleming - Pre-seed Investor
Taos Edmondson - Venture Partner
Portfolio
Serova Bio
OLIX
Prima Mente
ManyPets
Depop
Elvie
Pelago
Zoopla
Cazoo
LabGenius